TY  - JOUR
AU  - Periñán, María Teresa
AU  - Macías-García, Daniel
AU  - Jesús, Silvia
AU  - Martín-Rodríguez, Juan Francisco
AU  - Muñoz-Delgado, Laura
AU  - Jimenez-Jaraba, Maria Valle
AU  - Buiza-Rueda, Dolores
AU  - Bonilla-Toribio, Marta
AU  - Adarmes-Gómez, Astrid Daniela
AU  - Gómez-Garre, Pilar
AU  - Mir, Pablo
PY  - 2022
DO  - 10.1007/s00415-022-11361-y
UR  - http://hdl.handle.net/10668/20030
T2  - Journal of neurology
AB  - Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. To study the correlation between homocysteine levels and cognitive impairment in patients with PD. We conducted a case-control study that included 246 patients...
LA  - en
KW  - Cognitive impairment
KW  - Homocysteine
KW  - MTHFR
KW  - Meta-analysis
KW  - Parkinson’s disease
KW  - Humans
KW  - Parkinson Disease
KW  - Case-Control Studies
KW  - Vitamin B 12
KW  - Folic Acid
KW  - Cognitive Dysfunction
KW  - Genotype
KW  - Methylenetetrahydrofolate Reductase (NADPH2)
KW  - Genetic Background
KW  - Homocysteine
TI  - Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.
TY  - research article
VL  - 270
ER  -